Ultrasonographic and morphological studies of the postmenopausal endometrium using unopposed estrogen replacement therapy with regular pause: A prospective preliminary study

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 98, Issue 1, 2001, Pages 119-123

  Patriarca, Marisa T ^a   De Lima, Geraldo Rodrigues ^a   Stavale, João N ^a   Gonçalves, Wagner J ^a   Freitas, Vilmon ^a   Soares Jr , José M ^a   Simões, Manuel J ^a   Baracat, Edmund C ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Endometrial morphology; Endometrial thickness; Menopause; Transvaginal sonography; Unopposed estrogen therapy

Indexed keywords

CONJUGATED ESTROGEN; GESTAGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENDOMETRIUM BIOPSY; ENDOMETRIUM HYPERPLASIA; ESTROGEN THERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; MENSTRUAL CYCLE; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THICKNESS; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME;

EID: 0034873393     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(01)00286-X     Document Type: Article

References (34)

1. Practical aspects of hormone replacement therapy
2. Reduced mortality associated with long-term postmenopausal estrogen therapy
3. Balancing safety and efficacy focus on endometrial protection
4. Actions of progestins on the morphology and biochemistry of the endometrium of postmenopausal women receiving low-dose estrogen therapy
5. Progesterone and the risk of arterial and venous thrombosis
6. Effects of hormone replacement therapy on lipoprotein (a) and lipids in postmenopausal women
7. Progestagen in estrogen-replacement therapy
8. Estrogen replacement therapy in patients with endometrial cancer: Prescription attitude of Belgian gynecologists
9. Histomorphometry of the postmenopausal endometrium after oral and transdermal oestrogen replacement therapy
10. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy
11. Estrogens and progestins: What to use and how to use it
12. Metabolic impact of adding medroxiprogesterone acetate to conjugated estrogen therapy in postmenopausal women
13. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women
14. Monitoring of oestrogen replacement therapy by vaginosonography of the endometrium
15. Endometrial thickness assessed by transvaginal ultrasound insufficiently predicts occurrence hyperplasia during unopposed oestrogen use
16. The risk of breast cancer after estrogen and estrogen-progestin replacement
17. Links between hormone replacement therapy and neoplasia
18. Morphologic and morphometric aspects of the endometrium of postmenopausal women before and after cyclic oestrogen replacement treatment
19. Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding
20. Endometrial thickness as measured by endovaginal ultrasonography for identifying endometrial abnormality
21. A case-control study of uterine endometrial cancer of pre- and post-menopausal women
22. Histology of the human endometrium: From birth to senescence
23. The behavior of endometrial hyperplasia. A long-term study of untreated hyperplasia in 170 patients
24. Problems in the differential diagnosis of endometrial hyperplasia and carcinoma
25. The role of vaginal scan in measurement of endometrial thickness in post menopausal women
26. Change in endometrial thickness in postmenopausal women undergoing hormones replacement therapy
27. The benefits and risks of hormone replacement therapy: An epidemiologic overview
28. Comparison of endometrial growth produced by unopposed conjugated estrogens or by micronized estradiol in postmenopausal women
29. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogen (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone
30. Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase. Hormonal regulation in cultured stromal cells and messenger RNA expression during the menstrual cycle
31. Transvaginal ultrasonography for identifying endometrial pathology in postmenopausal women
32. Transvaginal sonography and hysteroscopy in women with postmenopausal bleeding
33. Endometrial response in estrogen replacement therapy quarterly combined with a progestogen
34. Adverse endometrial effects during long cycle hormone replacement therapy. Scandinavian long cycle study group